drugset / Trial / NCT00285155

Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers

NCT00285155

Completed 12 enrolled University Hospital, Montpellier
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate the effects of a 14-day repeated dose of 150 mg bupropion (therapeutic dose) on cognitive and executive functions, behaviour and subjective feelings, after sleep deprivation in 12 healthy male subjects.

Timeline

Start
2004-11
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg

Indications

No indication recorded.